Kuano CTO discusses Validating in-silico drug design with Quantum and AI

Jarryl D'Oyley 10/4/24 Jarryl D'Oyley 10/4/24

Kuano CTO discusses Validating in-silico drug design with Quantum and AI

Read More

Kuano makes significant strides towards novel bowel cancer therapy

Jarryl D'Oyley 8/30/24 Jarryl D'Oyley 8/30/24

Kuano makes significant strides towards novel bowel cancer therapy

Read More

Kuano CTO will be presenting at the Cambridge Cheminformatics Meeting

Jarryl D'Oyley 8/23/24 Jarryl D'Oyley 8/23/24

Kuano CTO will be presenting at the Cambridge Cheminformatics Meeting

Read More

Kuano talked to Foresight about Quantum Computing for Drug Design

Jarryl D'Oyley 8/12/24 Jarryl D'Oyley 8/12/24

Kuano talked to Foresight about Quantum Computing for Drug Design

Read More

Kuano Welcomes Dr David Barrett as Scientific Advisory Board member

Jarryl D'Oyley 5/10/24 Jarryl D'Oyley 5/10/24

Kuano Welcomes Dr David Barrett as Scientific Advisory Board member

Read More

Kuano is delighted to welcome Augustin Amour to the company

Jarryl D'Oyley 4/9/24 Jarryl D'Oyley 4/9/24

Kuano is delighted to welcome Augustin Amour to the company

Read More

Kuano is delighted to have recognised as one of the Top21 companies to watch in 2024

Jarryl D'Oyley 3/13/24 Jarryl D'Oyley 3/13/24

Kuano is delighted to have recognised as one of the Top21 companies to watch in 2024

Read More

The new EVP of Business Development is Cat Stace

Jarryl D'Oyley 2/29/24 Jarryl D'Oyley 2/29/24

The new EVP of Business Development is Cat Stace

Read More

Dr Ted Witek joins Kuano’s board of directors

Jarryl D'Oyley 2/20/24 Jarryl D'Oyley 2/20/24

Dr Ted Witek joins Kuano’s board of directors

Read More

Kuano has made the shortlist for the @cofinitive #21toWatch award.

Jarryl D'Oyley 2/16/24 Jarryl D'Oyley 2/16/24

Kuano has made the shortlist for the @cofinitive #21toWatch award.

Read More

Vid Stojevic, Kuano’s CEO is attending the J.P. Morgan Healthcare Conference

Jarryl D'Oyley 12/15/23 Jarryl D'Oyley 12/15/23

Vid Stojevic, Kuano’s CEO is attending the J.P. Morgan Healthcare Conference

Read More

Mercia discusses why they invested in Kuano

Jarryl D'Oyley 10/13/23 Jarryl D'Oyley 10/13/23

Mercia discusses why they invested in Kuano

Read More

"It's not just 3D simulation" - CEO discusses how investment will enable Kuano to transform computational drug design

Jarryl D'Oyley 9/26/23 Jarryl D'Oyley 9/26/23

"It's not just 3D simulation" - CEO discusses how investment will enable Kuano to transform computational drug design

Read More

Kuano raises £1.8M in seed funding round to accelerate quantum drug discovery.

Jarryl D'Oyley 9/12/23 Jarryl D'Oyley 9/12/23

Kuano raises £1.8M in seed funding round to accelerate quantum drug discovery.

Read More

Kuano has been featured by Oracle

Jarryl D'Oyley 7/14/23 Jarryl D'Oyley 7/14/23

Kuano has been featured by Oracle

Read More

Vid Stojevic, Kuano’s CEO is attending Bio-Europe Spring

Jarryl D'Oyley 3/16/23 Jarryl D'Oyley 3/16/23

Vid Stojevic, Kuano’s CEO is attending Bio-Europe Spring

Read More

Podcast: Kuano’s perspective on drug design

Jarryl D'Oyley 2/16/23 Jarryl D'Oyley 2/16/23

Podcast: Kuano’s perspective on drug design

Read More

Awarded: Innovate UK funding to design a new generation of cancer drugs

Jarryl D'Oyley 1/9/23 Jarryl D'Oyley 1/9/23

Awarded: Innovate UK funding to design a new generation of cancer drugs

Read More

The new Chief Operating Officer for Kuano is Denise Moody

David Wright 8/15/22 David Wright 8/15/22

The new Chief Operating Officer for Kuano is Denise Moody

Read More

Antonio Benedetti is appointed as Kuano’s new Chairperson

Jarryl D'Oyley 7/13/22 Jarryl D'Oyley 7/13/22

Antonio Benedetti is appointed as Kuano’s new Chairperson

Antonio is an experienced CEO with a demonstrated history of working in the pharmaceuticals (former CEO Cycle Pharmaceuticals) industry.

Read More